CRISPResso2 provides accurate and rapid genome editing sequence analysis

  • Nat Biotechnol. 2019 Mar;37(3):224-226. doi: 10.1038/s41587-019-0032-3.
Kendell Clement  1  2  3 ,  Holly Rees  4  5  6 ,  Matthew C Canver  1  2  3 ,  Jason M Gehrke  2  3 ,  Rick Farouni  1  2  3 ,  Jonathan Y Hsu  1  2  3 ,  Mitchel A Cole  7 ,  David R Liu  4  5  6 ,  J Keith Joung  2  3 ,  Daniel E Bauer  8  9  10  11 ,  Luca Pinello  12  13  14
Affiliations
  • 1. Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • 2. Molecular Pathology Unit, Center for Cancer Research and Center for Computational and Integrative Biology, Massachusetts General Hospital, Charlestown, MA, USA.
  • 3. Department of Pathology, Harvard Medical School, Boston, MA, USA.
  • 4. Merkin Institute of Transformative Technologies in Healthcare, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • 5. Howard Hughes Medical Institute, Harvard University, Cambridge, MA, USA.
  • 6. Department of Chemistry and Chemical Biology, Harvard University, Cambridge, MA, USA.
  • 7. Division of Hematology/Oncology, Boston Children's Hospital; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • 8. Broad Institute of MIT and Harvard, Cambridge, MA, USA. [email protected].
  • 9. Division of Hematology/Oncology, Boston Children's Hospital; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. [email protected].
  • 10. Department of Pediatrics, Harvard Medical School, Boston, MA, USA. [email protected].
  • 11. Harvard Stem Cell Institute, Cambridge, MA, USA. [email protected].
  • 12. Broad Institute of MIT and Harvard, Cambridge, MA, USA. [email protected].
  • 13. Molecular Pathology Unit, Center for Cancer Research and Center for Computational and Integrative Biology, Massachusetts General Hospital, Charlestown, MA, USA. [email protected].
  • 14. Department of Pathology, Harvard Medical School, Boston, MA, USA. [email protected].
PMID: 30809026 DOI: 10.1038/s41587-019-0032-3